Article
Chapter four--Design of improved oncolytic adenoviruses.
Advances in cancer research - 1 Jan 2012
Alemany Ramon
Abstract excerpt
During the last decade adenovirus has lost its appeal in gene therapy due to a high immunogenicity that leads to a transient gene expression. However, adenovirus has gained attention as replication-competent vector to treat cancer. Designed for virotherapy, adenovirus has been successfully modified to replicate selectively in tumor cells. After the initial clinical trials with tumor-selective adenoviruses, it has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
